C3 glomerulopathy: a new classification, Nat Rev Nephrol, vol.6, issue.8, pp.494-499, 2010. ,
C3 glomerulopathy: consensus report, Kidney Int, vol.84, issue.6, pp.1079-1089, 2013. ,
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies, Kidney Int, vol.82, issue.4, pp.454-464, 2012. ,
Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients, Clin J Am Soc Nephrol, vol.4, issue.1, pp.22-32, 2009. ,
Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H, Nat Genet, vol.31, issue.4, pp.424-428, 2002. ,
Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency, J Clin Invest, vol.95, issue.3, pp.1054-1061, 1995. ,
C3 nephritic factor associated with C3 glomerulopathy in children, Pediatr Nephrol, vol.29, issue.1, pp.85-94, 2014. ,
C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up, Kidney Int, vol.82, issue.4, pp.465-473, 2012. ,
Combined C3b and factor B autoantibodies and MPGN type II, N Engl J Med, vol.365, issue.24, pp.2340-2342, 2011. ,
Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk, Kidney Int, vol.69, issue.3, pp.504-511, 2006. ,
Eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.369, issue.14, pp.1379-1380, 2013. ,
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, issue.11, pp.643-657, 2012. ,
Eculizumab for dense deposit disease and C3 glomerulonephritis, Clin J Am Soc Nephrol, vol.7, issue.5, pp.748-756, 2012. ,
Eculizumab in a patient with dense-deposit disease, N Engl J Med, vol.366, issue.12, pp.1161-1163, 2012. ,
Eculizumab for the treatment of dense-deposit disease, N Engl J Med, vol.366, issue.12, pp.1163-1165, 2012. ,
Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice, Proc Natl Acad Sci, vol.103, issue.25, pp.9649-9654, 2006. ,
Pathology after eculizumab in dense deposit disease and C3 GN, J Am Soc Nephrol, vol.23, issue.7, pp.1229-1237, 2012. ,